Recent advances in the classification, neurobiology and treatment of premature ejaculation

Advances in Psychosomatic Medicine

Volumn 29, Issue , 2008, Pages 50-69

  Waldinger, M ^a,b  

^a HagaHospital Leyenburg ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR THERAPY; CLASSIFICATION; COITUS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EJACULATION; EVIDENCE BASED MEDICINE; HUMAN; HUMAN RELATION; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; METHODOLOGY; PHYSIOLOGY; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; PSYCHOSEXUAL DISORDER; REVIEW; SEXUAL COUNSELING; SEXUAL DYSFUNCTION; SEXUALITY;

BEHAVIOR THERAPY; COITUS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EJACULATION; EVIDENCE-BASED MEDICINE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERPERSONAL RELATIONS; MALE; PRACTICE GUIDELINES AS TOPIC; RESEARCH DESIGN; SEX COUNSELING; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SEXUAL PARTNERS;

EID: 46449094393     PISSN: 00653268     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000126624     Document Type: Review

References (32)

1. Waldinger MD: The neurobiological approach to premature ejaculation. J Urol 2002;168:2359-2367.
2. Waldinger MD: Lifelong premature ejaculation: from authority-based to evidence-based medicine. Brit J Urol Int 2004;93:201-207.
3. Masters WH, Johnson VE: Premature ejaculation; in Masters WH, Johnson VE (eds): Human Sexual Inadequacy. Little, Brown, Boston 1970, pp 92-115.
4. Waldinger MD, Hengeveld MW, Zwinderman AH: Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 1994;151:1377-1379.
5. Waldinger MD: Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. J Impot Res 2003;15:309-313.
6. Waldinger MD, Schweitzer DH: Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case. J Sex Med 2008; in press.
7. Waldinger MD, Schweitzer DH: Is Dapoxetine effective enough in delaying ejaculation in men with lifelong premature ejaculation? A critical review on the role of pharmaceutical companies. ISDB Newsletter 2008; in press.
8. Waldinger MD: Premature ejaculation: State of the art. Urol Clin North Am 2007;34:591-599.
9. Waldinger MD: Premature ejaculation: different pathophysiologies and etiologies determine its treatment. J Sex Marital Ther 2008;34:1-13.
10. Waldinger MD, Schweitzer DH: Changing paradigms from an historical DSM-III and DSM-IV view towards an evidence based definition of premature ejaculation. Part I: Validity of DSM-IV-TR. J Sex Med 2006;3:682-692.
11. Waldinger MD, Schweitzer DH: Changing paradigms from an historical DSM-III and DSM-IV view towards an evidence based definition of premature ejaculation. Part II: Proposals for DSM-V and ICD-11. J Sex Med 2006;3:693-705.
12. Waldinger MD: The need for a revival of psychoanalytic investigations into premature ejaculation. J Mens Health Gend 2006;3:390-396.
13. Waldinger MD, Schweitzer DH: The use of old and recent DSM definitions of premature ejaculation in observational studies: a contribution to the present debate for a new classification of PE in the DSM-V. J Sex Med 2008; in press.
14. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B: An empirical operationalization study of DSM-IV diagnostic criteria for premature ejaculation. Intern J Psychiatry Clin Pract 1998;2:287-293.
15. Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH: The majority of men with lifelong premature ejaculation prefer daily drug treatment: an observational study in a consecutive group of Dutch men. J Sex Med 2007;4:1028-1037.
16. Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M: A multinational population survey of intravaginal ejaculation latency time. J Sex Med 2005;2:492-497.
17. Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH: Proposal for a definition of lifelong premature ejaculation based on epidemiological stopwatch data. J Sex Med 2005;2:498-507.
18. Patrick DL, Althof SE, Pryor JL, Rosen R, Rowland DL, Ho KF, McNulty P, Rothman M, Jamieson C: Premature ejaculation: An observational study of men and their partners. J Sex Med 2005;2:358-367.
19. Giuliano F, Patrick DL, Porst H, La Pera G, Kokoszka A, Merchant S, Rothman M, Gagnon DD, Polverejan E for the 3004 Study Group: Premature ejaculation: results from a five-country European observational study. Eur Urol 2007; epub.
20. Waldinger MD, Schweitzer DH: The DSM-IV-TR is an inadequate diagnostic tool for premature ejaculation (letter). J Sex Med 2007;4:822-823.
21. Balon R, Segraves RT, Clayton A: Issues for DSM-V: Sexual dysfunction, disorder, or variation along normal distribution: Toward rethinking DSM criteria of sexual dysfunctions. Am J Psychiatry 2007;164:198-199.
22. Segraves R, Balon R, Clayton A: Proposal for changes in diagnostic criteria for sexual dysfunctions. J Sex Med 2007;4:567-580.
23. Segraves RT, Balon R: Toward an improved nosology of sexual dysfunctions in DSM-V. Psychiatric Times 2007;24:44-46.
24. St. Lawrence JS, Madakasira S: Evaluation and treatment of premature ejaculation: a critical review. Int J Psychiatr Med 1992;22:77-97.
25. Olivier B, van Oorschot R, Waldinger MD: Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour. Int Clin Psychopharmacol 1998;13 (suppl 6): S9-S14.
26. de Jong TR, Veening JG, Olivier B, Waldinger MD: Oxytocin involvement in SSRI-induced delayed ejaculation: a review of animal studies. J Sex Med 2007;4:14-28.
27. Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH: Geometric mean IELT and premature ejaculation: Appropriate statistics to avoid overestimation of treatment efficacy. J Sex Med 2008;5:492-499.
28. Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B: Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 2004;16:369-381.
29. Waldinger MD: Premature ejaculation: definition and drug treatment. Drugs 2007;67:547-568.
30. Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJG, Shabsigh R, Miloslavsky M, Kell S: Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet 2006;368:929-937.
31. Waldinger MD, Schweitzer DH, Olivier B: Dapoxetine treatment of premature ejaculation (Letter). Lancet 2006;368:1869-1870.
32. McMahon CG, McMahon CN, Liang JL, Winestock CG: Efficacy of type-5 phophodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review. BJU Int 2006;98:259-272.